Jiwangga Dhihintia, Mahyudin Ferdiansyah, Mastutik Gondo, Meitavany Estya Nadya
Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Int J Biomater. 2024 Feb 6;2024:3355239. doi: 10.1155/2024/3355239. eCollection 2024.
The process of decellularization is crucial for producing a substitute for the absent tracheal segment, and the choice of agents and methods significantly influences the outcomes. This paper aims to systematically review the efficacy of diverse tracheal decellularization agents and methods using the PRISMA flowchart. Inclusion criteria encompassed experimental studies published between 2018 and 2023, written in English, and detailing outcomes related to histopathological anatomy, DNA quantification, ECM evaluation, and biomechanical characteristics. Exclusion criteria involved studies related to 3D printing, biomaterials, and partial decellularization. A comprehensive search on PubMed, NCBI, and ScienceDirect yielded 17 relevant literatures. The integration of various agents and methods has proven effective in the process of tracheal decellularization, highlighting the distinct advantages and drawbacks associated with each agent and method.
去细胞化过程对于制造缺失气管段的替代物至关重要,试剂和方法的选择会显著影响结果。本文旨在使用PRISMA流程图系统评价多种气管去细胞化试剂和方法的疗效。纳入标准包括2018年至2023年间发表的英文实验研究,且详细阐述了与组织病理学解剖、DNA定量、细胞外基质评估和生物力学特征相关的结果。排除标准涉及与3D打印、生物材料和部分去细胞化相关的研究。在PubMed、NCBI和ScienceDirect上进行的全面检索产生了17篇相关文献。各种试剂和方法的整合在气管去细胞化过程中已被证明是有效的,突出了每种试剂和方法的独特优缺点。